Archive · 31 Jul 2025
Brokerages Recommend Buying Star Health Shares
Several financial companies like Goldman Sachs and Motilal Oswal think it's a good idea to buy shares of Star Health, an insurance company.
They believe the company will make more money.
Goldman Sachs thinks the shares could go up by about 17%.
Motilal Oswal points out the company's income is increasing.
Yes Securities also believes the stock will grow because of changes the company has made.
Many foreign investors also own shares in this company.
Goldman Sachs, Motilal Oswal, and Yes Securities recommend buying Star Health shares.
Goldman Sachs expects a 17.2% upside for Star Health shares, citing growth in gross written premium.
Motilal Oswal highlights a 12% rise in Star Health's net interest premiums.
Yes Securities expects gains due to price hikes and altered underwriting strategies.
Foreign investors hold a 13.76% stake in Star Health.
- Who
- Star Health and Allied Insurance Company Ltd.
- What
- Several firms recommend buying Star Health shares.
- When
- Recent reports.
- Where
- Indian stock market.
- Why
- Due to positive financial outlook and strategic actions.
- Goldman Sachs Target
- ₹500 (17.2% upside)
- Motilal Oswal Target
- ₹520 (16% upside)
- Yes Securities Target
- ₹540
- Foreign Stake
- 13.76%
- Current Share Price
- ₹444.50
- Market Cap
- ₹26,179.66 crore